Dimension is a venture capital firm specializing in early-stage investments at the intersection of technology and life sciences. Established in 2022, Dimension operates from offices in New York and San Francisco.
Dimension partners with entrepreneurs to build companies that leverage the convergence of computational technologies and biology. Their investment areas include:
Dimension seeks to catalyze the potential between computing and biology to transform life sciences.
Dimension Capital I:
Launched in 2022 with $350 million, focusing on early-stage investments in drug discovery, life sciences, machine learning, artificial intelligence, advanced manufacturing, and software sectors.
Dimension Capital II:
Closed in October 2024, raising $500 million to continue investing in startups at the intersection of technology and biology. This fund exceeded its $400 million target, reflecting strong investor interest.
Team
Dimension was co-founded by:
Notable Investments
Dimension's portfolio includes companies such as:
